concept

LECANEMAB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LECANEMAB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

104Connections

0Hypotheses

0Analyses

50Outgoing

34Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	LECANEMAB
Key Genes/Proteins	AMYLOID, AMYLOID-BETA, APOE, APOE4, APP, BACE1
Related Diseases	AGING, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID PLAQUES, AUTOPHAGY

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Lecanemab CLARITY Open-Label Extension

clinical · 2301 words

→

Pathway Diagram

graph TD
    LECANEMAB["LECANEMAB"]
    LECANEMAB -->|"treats"| Cognitive_Decline["Cognitive Decline"]
    LECANEMAB -->|"targets"| Amyloid_Beta["Amyloid Beta"]
    LECANEMAB -->|"targets"| Amyloid__["Amyloid-beta"]
    LECANEMAB -->|"targets"| AMYLOID_BETA["AMYLOID-BETA"]
    LECANEMAB -->|"treats"| Early_Stage_Alzheimer_s_Diseas["Early-Stage Alzheimer's Disease"]
    LECANEMAB -->|"targets"| Brain_Amyloid_Pathology["Brain Amyloid Pathology"]
    LECANEMAB -->|"targets"| Amyloid_Pathology["Amyloid Pathology"]
    Anticoagulation["Anticoagulation"] -->|"interacts"| LECANEMAB
    DONANEMAB["DONANEMAB"] -->|"target for"| LECANEMAB
    ADUCANUMAB["ADUCANUMAB"] -->|"target for"| LECANEMAB
    Amyloid["Amyloid"] -->|"interacts"| LECANEMAB
    AMYLOID["AMYLOID"] -->|"target for"| LECANEMAB
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"target for"| LECANEMAB

Outgoing (70)

Target	Relation	Type	Str
ad_clinical_trial_failures:lecanemab	data_in	dataset_row	0.00
ad_clinical_trial_failures:lecanemab	data_in	dataset_row	0.00
Amyloid β	targets	protein	0.95
Amyloid-Β	targets	protein	0.95
Amyloid-β	targets	protein	0.95
Cognitive Decline	treats	phenotype	0.95
amyloid-β	targets	compound	0.92
Brain Amyloid Pathology	targets	biomarker	0.90
Alzheimer'S Disease	treats	disease	0.90
Amyloid Pathology	targets	mechanism	0.90
Early-Stage Alzheimer's Disease	treats	disease	0.90
AMYLOID-BETA	targets	protein	0.90
Amyloid-Beta	targets	protein	0.90
Alzheimer's Disease	treats	disease	0.85
ALZHEIMER'S DISEASE	treats	disease	0.85
Amyloid-Beta Clearance	associated_with	process	0.85
Amyloid Related Imaging Abnormalities	causes	phenotype	0.85
Microhemorrhages	causes	phenotype	0.80
Macrohemorrhages	causes	phenotype	0.75
Infusion Reactions	causes	phenotype	0.75
neuroinflammation	treats	disease	0.75
ubiquitin-proteasome	modulates	pathway	0.75
Alzheimer's Disease	treats	disease	0.75
Alzheimer's disease	treats	disease	0.70
Amyloid	interacts_with	entity	0.70
Amyloid	inhibits	entity	0.70
Amyloid	activates	entity	0.70
blood-brain barrier	modulates	pathway	0.65
autophagy pathway	modulates	pathway	0.65
neurodegeneration	treats	disease	0.65
ALZHEIMER'S DISEASE	interacts_with	disease	0.65
neurotrophin signaling	modulates	pathway	0.65
AMYLOID	regulates	protein	0.65
AMYLOID PLAQUES	causes	phenotype	0.65
ALZHEIMER'S DISEASE	activates	disease	0.65
multiple sclerosis	treats	disease	0.60
NEURON	associated_with	cell_type	0.60
RNA	targets	gene	0.60
NEURON	stabilizes	cell_type	0.60
APOE	targets	gene	0.60
APOE4	targets	gene	0.60
BACE1	targets	gene	0.55
TREM2	targets	gene	0.55
STX17	targets	gene	0.55
purinergic signaling	modulates	pathway	0.55
insulin signaling	modulates	pathway	0.55
NGF	targets	gene	0.55
HSP70	targets	gene	0.55
BDNF	targets	gene	0.55
HDAC	targets	gene	0.55

Incoming (34)

Source	Relation	Type	Str
ad_clinical_trial_failures:lecanemab	data_in	dataset_row	0.00
ad_clinical_trial_failures:lecanemab	data_in	dataset_row	0.00
DONANEMAB	therapeutic_target	drug	0.80
ADUCANUMAB	targets	drug	0.80
Anticoagulation	interacts_with	process	0.80
Amyloid	interacts_with	entity	0.70
DEMENTIA	treats	disease	0.65
AMYLOID	therapeutic_target	protein	0.65
ALZHEIMER	treats	disease	0.65
ALZHEIMER'S DISEASE	treats	disease	0.65
MITOCHONDRIAL DYSFUNCTION	associated_with	phenotype	0.50
NEURODEGENERATION	associated_with	phenotype	0.50
INFLAMMATION	associated_with	phenotype	0.50
ALZHEIMER'S DISEASE	therapeutic_target	disease	0.50
PROTEIN AGGREGATION	associated_with	phenotype	0.50
PROTEOSTASIS	associated_with	phenotype	0.50
NEUROINFLAMMATION	associated_with	phenotype	0.50
AMYLOID-BETA	associated_with	protein	0.50
GANTENERUMAB	associated_with	drug	0.45
SOLANEZUMAB	associated_with	drug	0.45
CRENEZUMAB	associated_with	drug	0.45
DONANEMAB	associated_with	drug	0.45
AMYLOID	associated_with	protein	0.45
APOE	associated_with	gene	0.45
ALZHEIMER	associated_with	disease	0.45
MULTIPLE SCLEROSIS	associated_with	disease	0.45
CEREBRAL AMYLOID ANGIOPATHY	associated_with	disease	0.45
AMYLOID PLAQUES	associated_with	phenotype	0.45
DEMENTIA	associated_with	disease	0.45
COGNITIVE DECLINE	associated_with	phenotype	0.45
ADUCANUMAB	associated_with	drug	0.45
ALZHEIMER'S DISEASE	associated_with	disease	0.35
APOE	therapeutic_target	gene	0.35
DEMENTIA	therapeutic_target	disease	0.35

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning LECANEMAB in their description or question text

No additional research found